Traws Pharma
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.63-1.67-1.43-1.17
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-0.83$-0.81$-0.95$-1.16

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.01-12.77-14.00-10.57-6.35-81.28-66.38-17.91-21.87N/A-6.35
Price/Sales ratio
2.1345.29428.85177.1562.598.85K4.74K1.50K1.83KN/A62.59
Price/Book Value ratio
2.4358.45-28.8640.3811.80331.1623.2612.0038.84N/A11.80
Price/Cash Flow ratio
-0.78-15.88-14.16-9.58-6.56-88.62-55.06-20.85-23.11N/A-6.56
Price/Free Cash Flow ratio
-0.78-15.88-14.16-9.58-6.54-88.56-55.06-20.85-23.09N/A-6.54
Price/Earnings Growth ratio
0.01N/A0.350.120.090.891.193.4319.90N/A0.09
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%100%93.80%93.80%92.92%N/A100%
Operating Profit Margin
-209.25%-427.38%-3270.26%-1895.92%-993.99%-10819.48%-7299.11%-8684.51%-8981.41%N/A-993.99%
Pretax Profit Margin
-209.55%-354.36%-3059.59%-1672.14%-984.56%-10888.74%-7151.76%-8391.15%-8384.07%N/A-984.56%
Net Profit Margin
-209.31%-354.61%-3061.24%-1675.32%-985.02%-10890.47%-7151.76%-8391.15%-8384.07%N/A-985.02%
Effective Tax Rate
-0.06%-0.07%-0.05%0.60%-0.04%-0.01%1.98%1.13%N/AN/A-0.04%
Return on Assets
-102.27%-84.65%-483.87%-114.78%-90.82%-125.87%-29.13%-48.16%-83.53%N/A-90.82%
Return On Equity
-239.55%-457.69%206.07%-381.90%-185.78%-407.40%-35.04%-66.98%-177.54%N/A-185.78%
Return on Capital Employed
-151.33%-181.31%515.04%-245.46%-141.06%-250.80%-33.41%-62.65%-150.76%N/A-141.06%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
3.042.270.492.102.831.929.014.822.45N/A2.83
Cash ratio
2.602.110.402.012.741.899.004.812.25N/A2.74
Days of Sales Outstanding
47.912.0427.3610.4016.3858.4645.2246.8329.07N/A16.38
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A7.74K13.58KN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A7.78K13.63K29.07N/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A71.87K100.63K128.18KN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A-64.09K-87.00K-128.15KN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
2.345.40-0.423.322.043.231.201.392.12N/A2.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.72-2.85-30.26-18.48-9.54-99.89-86.22-72.09-79.34N/A-9.54
Free Cash Flow / Operating Cash Flow Ratio
11111.001.00111.00N/A1.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A